Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI

Table 3

Values of blood lipids at baseline and 7 days after PCI.

	Rosuvastatin (n = 90)	Ezetimibe/rosuvastatin (n = 81)	value
TC (mg/dl)
Baseline	177.50 ± 53.36	175.95 ± 48.34	0.83
Day 7	167.05 ± 49.50	151.20 ± 37.12	0.02
value	<0.01	<0.01
LDL-C (mg/dl)
Baseline	113.69 ± 40.99	114.08 ± 32.87	0.97
Day 7	106.73 ± 37.90	96.29 ± 22.82	0.04
value	<0.01	<0.01
HDL-C (mg/dl)
Baseline	39.44 ± 10.44	42.15 ± 10.44	0.13
Day 7	39.06 ± 9.28	40.22 ± 8.89	0.41
value	0.29	0.13
TG (mg/dl)
Baseline	183.29 ± 130.16	173.55 ± 122.19	0.47
Day 7	171.78 ± 146.10	168.24 ± 143.44	0.78
value	0.09	0.27

Values are presented as mean ± standard deviation.